about
Adaptive immunity in the liverA case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literatureUpdate on Autoimmune HepatitisRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseManagement of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroidsImmunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Cirrhosis and autoimmune liver disease: Current understandingAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsPresence of antibodies against self human leukocyte antigen class II molecules in autoimmune hepatitis.Review article: autoimmune hepatitis -- current management and challenges.Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.Diagnosis of Liver Involvement in Primary Sjögren Syndrome.Autoimmune Hepatitis in Hawai'i.Anti-mitochondrial M2 antibody-positive autoimmune hepatitisAutoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease.Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients.Mycophenolate mofetil as an alternative treatment for autoimmune hepatitisClinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population.Dapagliflozin-Induced Acute-on-Chronic Liver Injury.Autoimmune features in metabolic liver disease: a single-center experience and review of the literature.Paediatric autoimmune liver disease.Autoimmunity in 2013.Characteristics and outcome of autoimmune liver disease in Asian children.Human autoimmune diseases: a comprehensive update.Contemporary issues and future directions in autoimmune hepatitis.Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015).Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis.Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.Autoimmune hepatitis unmasked by nimesulide.NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.Versican: a novel modulator of hepatic fibrosis.Imaging of autoimmune hepatitis and overlap syndromes.In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.Vitamin D deficiency and insufficiency after pediatric liver transplantation.Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?Salidroside mediates apoptosis and autophagy inhibition in concanavalin A-induced liver injury.
P2860
Q26753195-C25C17DA-FA0A-481D-8555-FF93978239EDQ26778890-AE3EFC54-8642-4BCB-AA31-7940B3662001Q26781765-B87F0F0F-D0F1-4529-92C6-1C2620A2099DQ26827787-C8E6B135-87B0-4CEE-974B-1E49783B7200Q26859099-2A4912EF-C9D2-4790-8DDA-BACF42D01C46Q28069584-74232DB7-9853-4E3C-A632-0B54B75BAD72Q28070154-41B1A402-55AA-4B7C-8D12-27E710E2710EQ28087726-EA726CF6-2060-44A5-81AB-B17E0C26D17EQ33843821-8F0CFA1C-16D6-4176-91CA-D2CB6E3B904AQ34369116-6BC7B199-C487-4078-962E-B607E96D74B5Q35016702-0BDE3FE8-4BC1-4576-8E67-9A434A03C219Q35906036-6DB379B4-3DEC-4C40-853D-54DE39E7A650Q35954255-1114AF82-81CF-421D-9C5A-A9867B57E17FQ36081422-47258C42-7443-464D-91B1-F7DA9C7C1044Q36085618-54574D98-2063-46FE-84A5-8535862B4665Q36777826-9FE04EED-DCBB-4E82-8E7E-248E002F8D2DQ37080623-326B2691-ABA0-4F81-8E42-5A08084EA5E5Q37097604-2D634268-6D8C-4A82-999F-F2414705EF86Q37099403-BE264A86-45B3-47F9-9991-A0A9D4580C32Q37519248-CE62DE5D-8F2C-4DBF-BF85-D4C2FD8C2DD2Q38120662-9A18F994-5B1E-471F-AC37-0C21D4CB4328Q38133924-F527103D-6B94-44C0-A5E0-93F67172D96DQ38211189-F2FC4F59-9F7A-4513-9C35-B8FFD51268B2Q38383394-4647D6D6-BB0F-463E-A5B8-5BB7CF9503BBQ38554722-C9108F13-C8EF-447F-827C-63D2030BED5AQ38842072-B433C3D4-5CCC-46FD-961A-E5CFDF3248C3Q38930837-D92B112C-C948-431C-9130-B7C1BD350A6CQ39413389-82904A85-8949-4D79-B45A-DAEAF2F59FBDQ40235009-B2AEAF6F-0FBB-4CAF-9605-B107BED84A02Q41049474-E9EACE0F-9C03-458E-9D5C-044D6AA080C5Q47151158-04CC2981-377A-4931-8C9D-DFEF6E3192F4Q47993022-CF3DEA38-DA69-43B1-B997-760DDA673B62Q48257999-8722BDDD-D580-45FA-B584-5E03A6EFF03CQ52564630-162893C6-F878-4BBF-84DA-3496883BC5CEQ52889712-4922BC8A-8DD4-4624-B1A8-AE9505326166Q52938723-AECA90DB-5E6B-42A7-9972-87E468B11C42Q52945081-A76D10CC-ED03-4392-8F3C-6A094C8BC506Q54287427-D8CF7BDF-FBD9-43AE-ABD8-52DF27742D94Q54939025-E1E2CCE5-47AF-463D-981F-B3D5F2C36968Q54978043-B270973F-FB8C-4AFB-8B68-5E3DA416978C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autoimmune hepatitis: a comprehensive review.
@en
type
label
Autoimmune hepatitis: a comprehensive review.
@en
prefLabel
Autoimmune hepatitis: a comprehensive review.
@en
P2093
P1476
Autoimmune hepatitis: a comprehensive review.
@en
P2093
Charlotte R Grant
Diego Vergani
Giorgina Mieli-Vergani
Rodrigo Liberal
P304
P356
10.1016/J.JAUT.2012.11.002
P577
2012-12-04T00:00:00Z